drugset / Trial / NCT02982590
Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to compare the novel oral anticoagulant apixaban with the standard therapy of warfarin on the size reduction or resolution of left ventricular thrombus over 3 months.
Timeline
- Start
- 2016-11
- Primary completion
- 2018-11
- Completion
- 2018-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Apixaban | Small molecule | 5 mg | Oral |
| Comparator | Warfarin | Small molecule | — | — |